Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Operating Expenses: 2018-2024

Historic Operating Expenses for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $238.0 million.

  • CureVac N.V's Operating Expenses fell 34.73% to -$68.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.4 million, marking a year-over-year decrease of 7.81%. This contributed to the annual value of $238.0 million for FY2024, which is 6.61% up from last year.
  • CureVac N.V's Operating Expenses amounted to $238.0 million in FY2024, which was up 6.61% from $223.2 million recorded in FY2023.
  • In the past 5 years, CureVac N.V's Operating Expenses registered a high of $1.0 billion during FY2021, and its lowest value of -$189.2 million during FY2020.
  • Over the past 3 years, CureVac N.V's median Operating Expenses value was $223.2 million (recorded in 2023), while the average stood at $210.4 million.
  • As far as peak fluctuations go, CureVac N.V's Operating Expenses soared by 653.99% in 2021, and later tumbled by 83.77% in 2022.
  • CureVac N.V's Operating Expenses (Yearly) stood at -$189.2 million in 2020, then surged by 653.99% to $1.0 billion in 2021, then crashed by 83.77% to $170.1 million in 2022, then spiked by 31.24% to $223.2 million in 2023, then grew by 6.61% to $238.0 million in 2024.